📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine. (2023)

First Author: Brewitz L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.2c01627

PubMed Identifier: 36757959

Publication URI: http://europepmc.org/abstract/MED/36757959

Type: Journal Article/Review

Volume: 66

Parent Publication: Journal of medicinal chemistry

Issue: 4

ISSN: 0022-2623